. 1962 Jul:12:675-9.

[2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dimethylxanthine nicotinate]

[Article in German]

[Article in German]

H LENNARTZ. Arzneimittelforschung. 1962 Jul.

. 1962 Jul:12:675-9.

No abstract available

Similar articles

[ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
FRUHMANN H. FRUHMANN H. Med Welt. 1963 Oct 12;41:2084-7. Med Welt. 1963. PMID: 14134155 German. No abstract available.
[2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dimethylxanthine nicotinate].
STAMM H. STAMM H. Arzneimittelforschung. 1962 Jul;12:679-82. Arzneimittelforschung. 1962. PMID: 13916159 German. No abstract available.
[2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dim-exthylxanthinenicotinate on cerebrospinal fluid pressure and cerebral circulation].
HEMMER R, DIEZEMANN E. HEMMER R, et al. Arzneimittelforschung. 1962 Jul;12:672-5. Arzneimittelforschung. 1962. PMID: 13906366 German. No abstract available.
[The treatment of acute cerebrovascular disorders by the nicotinic acid ester of 7-(2-hydroxyethyl)-theophylline (hesotin)].
BARTOUSEK V, CERNY J, DUBANSKY B. BARTOUSEK V, et al. Ther Umsch. 1960 May;17:182-5. Ther Umsch. 1960. PMID: 13797315 German. No abstract available.
CURRENT THERAPEUTIC CONCEPTS OF CEREBRAL AND MYOCARDIAL VASCULAR DISEASE.
FAZEKAS JF, ALMAN RW, TICKTIN HE, EHRMANTRAUT WR, SAVARESE CJ. FAZEKAS JF, et al. Angiology. 1964 Feb;15:63-9. doi: 10.1177/000331976401500201. Angiology. 1964. PMID: 14118543 Review. No abstract available.

[Brain metabolism studies under the treatment with pyrithioxin].
Becker K, Hoyer S. Becker K, et al. Dtsch Z Nervenheilkd. 1966 Mar 8;188(3):200-9. Dtsch Z Nervenheilkd. 1966. PMID: 5983388 German. No abstract available.